Osteoarthritis: can anti-cytokine therapy play a role in treatment?
about
Recognition of Immune Response for the Early Diagnosis and Treatment of Osteoarthritis.Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.Characterizing heterogeneity in the response of synovial mesenchymal progenitor cells to synovial macrophages in normal individuals and patients with osteoarthritisAIMP1 downregulation restores chondrogenic characteristics of dedifferentiated/degenerated chondrocytes by enhancing TGF-β signal.Immunopathogenesis of osteoarthritisDifferentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy eraInterleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis.Bovine lactoferricin induces TIMP-3 via the ERK1/2-Sp1 axis in human articular chondrocytes.Bovine lactoferricin-induced anti-inflammation is, in part, via up-regulation of interleukin-11 by secondary activation of STAT3 in human articular cartilageSuppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.Soluble mediators in posttraumatic wrist and primary knee osteoarthritis.Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis.Evaluation of a Single Intra-Articular Injection of Autologous Protein Solution for Treatment of Osteoarthritis in a Canine Population.Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis.Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes.Biological Effects of Phosphocitrate on Osteoarthritic Articular ChondrocytesMillimeter Wave Treatment Inhibits Apoptosis of Chondrocytes via Regulation Dynamic Equilibrium of Intracellular Free Ca (2+).Topical Effects of Artemisia Absinthium Ointment and Liniment in Comparison with Piroxicam Gel in Patients with Knee Joint Osteoarthritis: A Randomized Double-Blind Controlled Trial.Anti-Inflammatory Activity in the Low Molecular Weight Fraction of Commercial Human Serum Albumin (LMWF5A).Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis.Osteoarthritis is what the people have.MiR-193b regulates early chondrogenesis by inhibiting the TGF-beta2 signaling pathway.VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction.The IL-1β/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis.MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3.Effects of a phosphocitrate analogue on osteophyte, subchondral bone advance, and bone marrow lesions in Hartley guinea pigs.
P2860
Q28085009-684E37E2-060C-48B7-81A6-232F0C6E5CC2Q28393054-2B989FF0-AB94-41B1-8E25-B5D799D85F00Q30386272-8301859D-3D5C-4B19-94B0-5C06DED5DEB0Q33586806-DFBDA500-432E-4383-89CB-5A2C8C3E011FQ33587966-A5EBA807-CA1C-4D6D-A49A-0E466B754092Q34727681-8CEF95FA-1A07-4B83-882A-94CC816E3D46Q35754521-150934B1-D040-4BF9-B35E-1BCCEE6527A3Q36612357-9BE3DD37-CA7D-4193-A5AD-B384792CDC8EQ37272126-16BA0AF9-94F7-4ED2-A1CC-22166A10EB7FQ37608884-487744D9-48C2-4DF3-B93B-749A1464D9C1Q39100069-1A560890-8925-4F19-A6BB-860ADE7D4DF6Q39154718-A819EE3C-55C2-40FB-B81D-92BB56083746Q39621080-F17122E5-FBE6-4222-BD37-ECCBBE695266Q40099130-5596BC7A-919C-4378-BE29-7387B2D22E00Q41182614-C4D986FA-FCD2-426E-9E98-ADD2B40C4D7DQ41836157-50B87E66-2F9A-46F0-8EF4-306C87B9B005Q43143555-841DB83B-796A-4897-AEA0-053D54FB236CQ46542412-B3D67858-79DF-44AE-A78D-E307B4857331Q47388109-3938092B-968D-4597-BE4E-B0E42379CEA6Q52613681-74972326-3DF3-43B5-8257-9053968B2E26Q52679053-0E688742-7106-4B3B-B037-5292A893FC9CQ52864429-2C210E7D-6C3F-4E70-864F-4D81985C8FB2Q54172438-BA7424D7-72E6-4146-9EE4-2C1A26F433DCQ54569255-903377B4-BA60-471A-A1AF-58ADBBB2B999Q55025580-26F40DEE-FE74-4919-8D8D-8162B85FE09EQ55333219-053396F5-A3C2-44BF-916F-623F411008C6Q55386211-4B2D3B6B-6D60-4E5A-880D-A173495DBEB7
P2860
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@en
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@nl
type
label
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@en
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@nl
prefLabel
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@en
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@nl
P2093
P1476
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
@en
P2093
Ana Luisa G Calich
Diogo S Domiciano
Ricardo Fuller
P2860
P304
P356
10.1007/S10067-009-1352-3
P577
2010-01-27T00:00:00Z